Ibars M, Ardid-Ruiz A, Suárez M, Muguerza B, Bladé C, Aragonès G
Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Campus Sescelades, Tarragona, Spain.
Int J Obes (Lond). 2017 Jan;41(1):129-136. doi: 10.1038/ijo.2016.169. Epub 2016 Sep 28.
Dietary obesity is usually linked with hypothalamic leptin resistance, in which the primary impact is an interference in the homeostatic control of body weight and appetite. Notably, proanthocyanidins (PACs), which are the most abundant phenolic compounds present in human diet, modulate adiposity and food intake. The aim of this study was to assess whether PACs could re-establish appropriate leptin signalling in both the hypothalamus and peripheral tissues.
Male Wistar rats were fed either a standard chow diet (STD group, n=7) or a cafeteria diet (CD) for 13 weeks. The CD-fed rats were treated with either grape-seed PAC extract (GSPE) at 25 mg per kg of body weight per day (CD+GSPE group, n=7) or with the vehicle (CD group, n=7) for the last 21 days of the study period. Specific markers for intracellular leptin signalling, inflammation and endoplasmic reticulum stress in the hypothalamus, liver, mesenteric white adipose tissue and skeletal muscle were analysed using immunoblotting and quantitative PCR.
GSPE treatment significantly reduced the food intake but did not reverse the hyperleptinemia and body wt gain assessed. However, the animals treated with GSPE exhibited greater hypothalamic activation of signal transducer and activator of transcription-3, which was associated with a rise in the Pomc mRNA levels compared with the CD group. In addition, this restoration of leptin responsiveness was accompanied by lower local inflammation and increased Sirt1 gene expression. The effects of the GSPE treatment in the peripheral tissues were not as evident as those in the hypothalamus, although the GSPE treatment significantly restored the mRNA levels of Socs3 and Ptp1b in the skeletal muscle.
The use of GSPE reduces hyperphagia and improves the central and peripheral leptin resistance associated with diet-induced obesity. Our results suggest that GSPE could exert these effects partially by increasing Sirt1 expression and preventing hypothalamic inflammation.
饮食性肥胖通常与下丘脑瘦素抵抗有关,其主要影响是干扰体重和食欲的稳态控制。值得注意的是,原花青素(PACs)是人类饮食中最丰富的酚类化合物,可调节肥胖和食物摄入。本研究的目的是评估PACs是否能在下丘脑和外周组织中重新建立适当的瘦素信号传导。
雄性Wistar大鼠分别喂食标准饲料(STD组,n = 7)或自助餐饮食(CD)13周。在研究期的最后21天,给喂食CD的大鼠每天每千克体重注射25毫克葡萄籽PAC提取物(GSPE)(CD + GSPE组,n = 7)或溶剂(CD组,n = 7)。使用免疫印迹和定量PCR分析下丘脑、肝脏、肠系膜白色脂肪组织和骨骼肌中细胞内瘦素信号传导、炎症和内质网应激的特定标志物。
GSPE治疗显著减少了食物摄入量,但并未逆转所评估的高瘦素血症和体重增加。然而,与CD组相比,用GSPE治疗的动物下丘脑信号转导和转录激活因子-3的激活程度更高,这与Pomc mRNA水平的升高有关。此外,瘦素反应性的这种恢复伴随着局部炎症的降低和Sirt1基因表达的增加。GSPE治疗在外周组织中的作用不如在下丘脑中明显,尽管GSPE治疗显著恢复了骨骼肌中Socs3和Ptp1b的mRNA水平。
使用GSPE可减少食欲亢进,并改善与饮食诱导的肥胖相关的中枢和外周瘦素抵抗。我们的结果表明,GSPE可能部分通过增加Sirt1表达和预防下丘脑炎症来发挥这些作用。